×
Verification Code:
换一张
Forgotten Password?
Stay signed in
×
Login
中文
|
English
BNBU
|
Library
Login
Register
Home
Publications
Faculty/School
Scholars
Analysis
Search
ALL
ORCID
Title
Creator
Date Issued
Keyword
Document Type
Original Document Type
Indexed By
Publisher
Status
Collection
Authors
Document Type
Journal article
2
Date Issued
2022
1
2021
1
Language
英语English
2
Indexed By
SCIE
2
Funding Organization
Keyword
Artificial intelligence
1
Checkpoint inhibitors
1
Chemotherapy
1
Endocrine therapy
1
Immune
1
Major pathological response
1
More...
Source Publication
Cancer research and treatme...
1
Journal of Thoracic Disease
1
Funding Project
×
Knowledge Map
Feedback
Browse/Search Results: 1-2 of 2
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Journal Impact Factor Ascending
Journal Impact Factor Descending
Submit date Ascending
Submit date Descending
Author Ascending
Author Descending
Issue Date Ascending
Issue Date Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Title Ascending
Title Descending
Clinical Evidence of Chemotherapy or Endocrine Therapy Maintenance in Patients with Metastatic Breast Cancer: Meta-Analysis of Randomized Clinical Trials and Propensity Score Matching of Multicenter Cohort Study
Journal article
Cancer research and treatment,2022, volume: 54, issue: 4, pages: 1038-1052
Authors:
Ren, Wei
;
Yu, Yunfang
;
Hong, Huangming
;
Wang, Ying
;
Gao, Quanlong
Favorite
  |  
View/Download:4/0
  |  
Submit date:2022/11/14
Chemotherapy
Endocrine therapy
Metastatic breast neoplasms
Overall survival
Progression-free survival
Neoadjuvant camrelizumab, nab-paclitaxel, and carboplatin in patients with stage IB-IIIA non-small cell lung cancer (NANE-LC): A study protocol of prospective, single-arm, multicenter, phase II study
Journal article
Journal of Thoracic Disease,2021, volume: 13, issue: 11, pages: 6468-6475
Authors:
Zhou, Haiyu
;
Lin, Lili
;
Qin, Tao
;
Ren, Wei
;
Tan, Yujie
Favorite
  |  
View/Download:6/0
  |  
Submit date:2022/02/23
Artificial intelligence
Checkpoint inhibitors
Immune
Major pathological response
Neoadjuvant therapy
Non-small cell lung cancer (NSCLC)